IndiaTickerLatest filing: Medicamen Biotech Ltd-$ - 531146 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
ObservedCompany dossier
Medicamen Biotech
NSE:MEDICAMEQ · ISIN INE646B01010
- Close
- ₹238.2 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Medicamen Biotech
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹45.1 Cr · PAT ₹2.9 Cr.
Exchange XBRLLatest ownership: promoter group 40.46% and public 59.54% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Medicamen Biotech Ltd-$ - 531146 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
BSE · exchange filing
Observed
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Medicamen Biotech Limited
NSE · exchange filing
Observed
Source filing Medicamen Biotech Ltd-$ - 531146 - Closure of Trading Window
BSE · exchange filing
Observed
Source filing Trading Window - Medicamen Biotech Limited
NSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹45.1 Cr
- Profit after tax
- ₹2.9 Cr
- EPS
- ₹2.30
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 40.46%
- Public
- 59.54%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL